Photo Release -- Enzymotec Ltd. Awarded the Title of Outstanding Exporter for 2012
07 February 2014 - 8:05AM
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients, announced
today that it received the title of Outstanding Exporter for 2012
from the Israeli Ministry of Economy. Certificates and awards for
Outstanding Exporter were presented to Enzymotec's CEO, Dr. Ariel
Katz, and Vice President - Research and Development, Dr. Tzafra
Cohen, by the President of Israel, Mr. Shimon Peres and the
Minister of Economy, Mr. Naftali Bennett, at a ceremony held at the
Presidential Residence in Jerusalem.
A photo accompanying this release is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=23475
Enzymotec received the award of Outstanding Exporter based on
its notable growth in exports, as part of the Company's successful
strategy to grow international sales.
"We are honored to receive this award, which underlines our
continuous business success and growing demand for our products,"
said Dr. Ariel Katz, President and Chief Executive Officer of
Enzymotec Ltd. "This recognition is a result of a true team effort
and I want to thank all of our employees for their hard work and
dedication. We are very proud to be one of the leading suppliers of
nutritional products and we look forward to expanding our global
customer base."
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies. For more information, visit www.enzymotec.com.
Forward Looking Statement
This release may contain forward-looking statements, which
express the current beliefs and expectations of Enzymotec's
management. Such statements involve a number of known and unknown
risks and uncertainties that could cause our future results,
performance or achievements to differ significantly from the
results, performance or achievements expressed or implied by such
forward-looking statements. Important factors that could cause or
contribute to such differences the following risks: a high
proportion of the sales of our InFat product is sold to end users
by a single company in China; we rely on our Swedish joint venture
partner to manufacture InFat, and certain matters related to the
joint venture are the subject of disagreement; our gross profits
may be adversely affected if we are only able to obtain lower
quality krill meal; our ability to obtain krill may be affected by
conservation regulation or initiatives; we are dependent on a
single facility that houses the majority of our operations; we may
not be able to expand our production or processing capabilities or
satisfy growing demand; our product development cycle is lengthy
and uncertain, and our development or commercialization efforts for
our products may be unsuccessful; we are subject to significant and
increasing government regulations regarding the sale and marketing
of our products; we may not be able to protect our proprietary
technology or prevent its unauthorized use by third parties; we are
currently subject to litigation, and in the future may become
subject to additional litigation, regarding intellectual property
rights; and other factors discussed under the heading "Risk
Factors" in Enzymotec's final prospectus for its initial public
offering filed with the Securities and Exchange Commission on
September 30, 2013. Forward-looking statements in this release are
made pursuant to the safe harbor provisions contained in the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are made only as of the date hereof, and
Enzymotec undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
The photo is also available via AP PhotoExpress.
CONTACT: ICR, LLC
Katie Turner
646-277-1228
-or-
John Mills
310-954-1105
John.Mills@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024